These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

803 related items for PubMed ID: 23117851

  • 1. Nonalcoholic fatty liver disease in lean individuals in the United States.
    Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, Srishord M.
    Medicine (Baltimore); 2012 Nov; 91(6):319-327. PubMed ID: 23117851
    [Abstract] [Full Text] [Related]

  • 2. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL, Petta S, Lombardi R, Pisano G, Russello M, Consonni D, Di Marco V, Cammà C, Mensi L, Dongiovanni P, Valenti L, Craxì A, Fargion S.
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [Abstract] [Full Text] [Related]

  • 3. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
    Akyuz U, Yesil A, Yilmaz Y.
    Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN, Conjeevaram Selvakumar PK, Watt K, Lopez R, Akras Z, Zein N, Carey W, Alkhouri N.
    Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children].
    Shi HB, Fu JF, Liang L, Wang CL, Zhu JF, Zhou F, Zhao ZY.
    Zhonghua Er Ke Za Zhi; 2009 Feb; 47(2):114-8. PubMed ID: 19573457
    [Abstract] [Full Text] [Related]

  • 11. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
    Golabi P, Paik JM, Kumar A, Al Shabeeb R, Eberly KE, Cusi K, GunduRao N, Younossi ZM.
    Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease.
    Pacifico L, Di Martino M, De Merulis A, Bezzi M, Osborn JF, Catalano C, Chiesa C.
    Hepatology; 2014 Feb; 59(2):461-70. PubMed ID: 23843206
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.
    Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, Koteish A, Brancati FL, Clark JM.
    Am J Epidemiol; 2013 Jul 01; 178(1):38-45. PubMed ID: 23703888
    [Abstract] [Full Text] [Related]

  • 15. Nonalcoholic steatohepatitis and the cardiometabolic syndrome.
    Abdeen MB, Chowdhury NA, Hayden MR, Ibdah JA.
    J Cardiometab Syndr; 2006 Jul 01; 1(1):36-40. PubMed ID: 17675901
    [Abstract] [Full Text] [Related]

  • 16. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.
    Yılmaz Y, Kanı HT, Demirtaş CÖ, Kaya E, Sapmaz AF, Qutranji L, Alkayyali T, Batun KD, Batman M, Toy B, Çiftaslan A.
    Turk J Gastroenterol; 2019 Oct 01; 30(10):892-898. PubMed ID: 31258138
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J, Ranchal I, Gallego-Durán R, Pareja MJ, Del Campo JA, Pastor-Ramírez H, Rico MC, Picón R, Pastor L, García-Monzón C, Andrade R, Romero-Gómez M.
    J Gastroenterol Hepatol; 2016 Sep 01; 31(9):1611-8. PubMed ID: 26946071
    [Abstract] [Full Text] [Related]

  • 19. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
    Weinstein G, Zelber-Sagi S, Preis SR, Beiser AS, DeCarli C, Speliotes EK, Satizabal CL, Vasan RS, Seshadri S.
    JAMA Neurol; 2018 Jan 01; 75(1):97-104. PubMed ID: 29159396
    [Abstract] [Full Text] [Related]

  • 20. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.
    Younossi ZM, Otgonsuren M, Venkatesan C, Mishra A.
    Metabolism; 2013 Mar 01; 62(3):352-60. PubMed ID: 22999011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.